212P Augmenting cancer immunotherapy by targeting the fes kinase. (December 2022) - Laight, B.J.; Dmytryk, N.; Harper, D.; Shakfa, N.; Hoskin, V.; Shapovalov, I.; Gao, Y.; Koti, M.; Greer, P.A.